Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saliva gentamicin monitoring in neonates
NL-OMON48679Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Oct 2018
- Modality
- Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Open-label, single-arm trial of gentamicin in Infection, sponsored by Amsterdam University Medical Center. Primary endpoint: Saliva gentamicin concentrations at different time points. Started Oct 2018; status: active, not recruiting.
02
Drugs
gentamicin
03
Conditions
Infection
Beyond the preview
Go deeper on NL-OMON48679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON48679.